Literature DB >> 18784742

Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol.

M Zaher, I Akrout, M Mirshahi, J-P Kolb, C Billard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784742     DOI: 10.1038/leu.2008.239

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression.

Authors:  James T Lynch; Ramkumar Rajendran; Georgia Xenaki; Ilhem Berrou; Constantinos Demonacos; Marija Krstic-Demonacos
Journal:  Mol Cancer       Date:  2010-02-15       Impact factor: 27.401

2.  Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.

Authors:  Faten Merhi; Ruoping Tang; Marion Piedfer; Julie Mathieu; Isabelle Bombarda; Murhaf Zaher; Jean-Pierre Kolb; Christian Billard; Brigitte Bauvois
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

3.  CK2 and PI3K are direct molecular targets of quercetin in chronic lymphocytic leukaemia.

Authors:  Maria Russo; Alfonsina Milito; Carmela Spagnuolo; Virginia Carbone; Anders Rosén; Paola Minasi; Fabio Lauria; Gian Luigi Russo
Journal:  Oncotarget       Date:  2017-06-27

4.  The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.

Authors:  Seila Lorenzo-Herrero; Christian Sordo-Bahamonde; Gabriel Bretones; Ángel R Payer; Ana P González-Rodríguez; Esther González-García; Jhudit Pérez-Escuredo; Mónica Villa-Álvarez; Luz-Elena Núñez; Francisco Morís; Segundo Gonzalez; Alejandro López-Soto
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

Review 5.  Apoptosis inducers in chronic lymphocytic leukemia.

Authors:  Christian Billard
Journal:  Oncotarget       Date:  2014-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.